Examination of the ratio of breast/ovarian cancer revealed that mutations that mapped to the N-terminus of the BRCA1 protein (including missense mutations and protein-truncating mutations that deleted the BRCT domains) exhibited a higher ratio of breast/ovarian cancers than did mutations mapping to the C-terminal portion of the BRCA1 gene. The gene discussed is BRCA1; the disease is ovarian carcinoma.